China 3D cardiac mapping Market by Application and End User: Opportunity Analysis and Industry Forecast, 2020-2027

The China 3D cardiac mapping market was valued at $55.55 million in 2019 and is projected to reach $150.59 million by 2027, registering a CAGR of 12.8% from 2020 to 2027. Cardiac mapping is the process of identifying electrical or mechanical activity of human heart. Mapping electrical movements of heart is a critical component for diagnosis and treatment of any heart disease. Cardiac mapping is generally performed by inserting a catheter into the heart chamber percutaneously and sequentially recording endocardial electrograms within a precise location within the heart. 3D cardiac mapping systems give three-dimensional view of a patient’s heart, which helps electrophysiologists to identify the site of origin of any irregular rhythm accurately and deliver radio-frequency catheter ablation therapy with high success rate. Moreover, cardiac mapping is used widely for identification, characterization, and localization of arrhythmia.

Surge in the prevalence of cardiac arrhythmias and increased demand for improved patient outcomes mainly boosts market growth. Cardiac arrhythmias have increased the incidences of other risk factors such as CVDs, high blood pressure, obesity, and diabetes. The chances of developing cardiac arrhythmias increases with increase in age. The common type of cardiac arrhythmias is atrial fibrillation, which causes an irregular and fast heart beat; there are numerous factors responsible for irregular heart rhythm such as heart attack, smoking, congenital heart defects, and stress. Improving life expectancies of people has considerably increased the geriatric population across the globe. These aspects have increased the demand for early detection and treatment of irregular heartbeat, thereby driving the demand for 3D cardiac mapping systems.

The China 3D cardiac mapping market is segmented on the basis of application and end user. By application, it is divided into electroanatomical mapping, basket catheter mapping, and real-time positional management (cardiac pathways) EP system. By end user, it is segmented into hospitals, clinics and diagnostics centers

Some of the key players operating in the market include Abbott Laboratories, Microport Scientific Corporation, Medtronic Plc, and Acutus Medical.

KEY MARKET SEGMENTS

By Application

Electroanatomical Mapping
Basket Catheter Mapping
Real-Time Positional Management (Cardiac Pathways) EP System.

By End User

Hospitals
Clinics
Diagnostics

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
Microport Scientific Corporation
Medtronic Plc
Acutus Medical

Frequently Asked Questions about the Chinese 3D Cardiac Mapping Market

What is the estimated value of the Chinese 3D Cardiac Mapping Market?

The Chinese 3D Cardiac Mapping Market was estimated to be valued at $55.55 million in 2019.

What is the growth rate of the Chinese 3D Cardiac Mapping Market?

The growth rate of the Chinese 3D Cardiac Mapping Market is 13.3%, with an estimated value of $150.59 million by 2027.

What is the forecasted size of the Chinese 3D Cardiac Mapping Market?

The Chinese 3D Cardiac Mapping Market is estimated to be worth $150.59 million by 2027.

Who are the key companies in the Chinese 3D Cardiac Mapping Market?

Key companies in the Chinese 3D Cardiac Mapping Market include Abbott Laboratories, Microport Scientific Corporation and Acutus Medical.

Report Attribute	Details
No. of Pages	75
Published	June 2020
Forecast Period	2019 - 2027
Estimated Market Value ( USD ) in 2019	$ 55.55 million
Forecasted Market Value ( USD ) by 2027	$ 150.59 million
Compound Annual Growth Rate	13.3%
Regions Covered	China
No. of Companies Mentioned	4

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary

2.1. CXO Perspective

Chapter 3: Market Overview

3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’sFive Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Surge in Prevalence of Cardiac Arrhythmias
3.4.1.2. Rise in Geriatric Population.
3.4.1.3. Growth in Preference for Minimally Invasive Procedures
3.4.2. Restraint
3.4.2.1. High Cost of 3D Cardiac Mapping Systems
3.4.3. Opportunity
3.4.3.1. Rise in Preference for 3D Cardiac Mapping
3.4.3.2. Rise in the Healthcare Expenditure in China
3.5. Impact of Government Regulations on China 3D Cardiac Mapping Market

Chapter 4: China 3D Cardiac Mapping Market, by Technology

4.1. Overview
4.1.1. Market Size and Forecast
4.2. Electroanatomical Mapping
4.2.1. Key Market Trends, Growth Factors, and Opportunities
4.2.2. Market Size and Forecast, by Region
4.3. Basket Catheter Mapping
4.3.1. Key Market Trends, Growth Factors, and Opportunities
4.3.2. Market Size and Forecast, by Region
4.4. Real-Time Positional Management (Cardiac Pathways) Ep System
4.4.1. Key Market Trends, Growth Factors, and Opportunities
4.4.2. Market Size and Forecast, by Region

Chapter 5: China 3D Cardiac Mapping Market, by End-user

5.1. Overview
5.1.1. Market Size and Forecast
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors, and Opportunities
5.2.2. Market Size and Forecast
5.3. Clinics
5.3.1. Key Market Trends, Growth Factors, and Opportunities
5.3.2. Market Size and Forecast
5.4. Diagnostics Centers
5.4.1. Key Market Trends, Growth Factors, and Opportunities
5.4.2. Market Size and Forecast

Chapter 6: Company Profiles

6.1. Abbott Laboratories
6.1.1. Company Overview
6.1.2. Company Snapshot
6.1.3. Operating Business Segments
6.1.4. Product Portfolio
6.1.5. Business Performance
6.1.6. Key Strategic Moves and Developments
6.2. Acutus Medical
6.2.1. Company Overview
6.2.2. Company Snapshot
6.2.3. Operating Business Segments
6.2.4. Product Portfolio
6.2.5. Key Strategic Moves and Developments
6.3. Microport Scientific Corporation
6.3.1. Company Overview
6.3.2. Company Snapshot
6.3.3. Operating Business Segments
6.3.4. Product Portfolio
6.3.5. Business Performance.
6.4. Medtronic plc.
6.4.1. Company Overview
6.4.2. Company Snapshot
6.4.3. Operating Business Segments
6.4.4. Product Portfolio
6.4.5. Business Performance
6.4.6. Key Strategic Moves and Developments

Companies Mentioned

Abbott Laboratories
Microport Scientific Corporation
Medtronic Plc
Acutus Medical

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic news articles and other related releases for market evaluation
Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

LOADING...